ReviewDrug design, development and therapy2026

Oral Obesity Medicines in the Era of Cardiovascular-Kidney-Metabolic Syndrome (CKM): Beyond Weight Loss Toward Disease Modification.

Abdulhameed Alhazmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.